Cite
A high-affinity [ 18 F]-labeled phosphoramidate peptidomimetic PSMA-targeted inhibitor for PET imaging of prostate cancer
MLA
Clifford E. Berkman, et al. “A High-Affinity [ 18 F]-Labeled Phosphoramidate Peptidomimetic PSMA-Targeted Inhibitor for PET Imaging of Prostate Cancer.” Nuclear Medicine and Biology, vol. 42, no. 10, Oct. 2015, pp. 780–87. EBSCOhost, https://doi.org/10.1016/j.nucmedbio.2015.06.003.
APA
Clifford E. Berkman, Hendry Cahaya, Stephanie T. Murphy, Joseph E. Blecha, Shorouk Dannoon, Tanushree Ganguly, Salma Jivan, Ella F. Jones, Cyril Barinka, Christopher R. Drake, Henry F. VanBrocklin, & Mark R. Hopkins. (2015). A high-affinity [ 18 F]-labeled phosphoramidate peptidomimetic PSMA-targeted inhibitor for PET imaging of prostate cancer. Nuclear Medicine and Biology, 42(10), 780–787. https://doi.org/10.1016/j.nucmedbio.2015.06.003
Chicago
Clifford E. Berkman, Hendry Cahaya, Stephanie T. Murphy, Joseph E. Blecha, Shorouk Dannoon, Tanushree Ganguly, Salma Jivan, et al. 2015. “A High-Affinity [ 18 F]-Labeled Phosphoramidate Peptidomimetic PSMA-Targeted Inhibitor for PET Imaging of Prostate Cancer.” Nuclear Medicine and Biology 42 (10): 780–87. doi:10.1016/j.nucmedbio.2015.06.003.